193 related articles for article (PubMed ID: 29190165)
41. Topical pharmacotherapy for ocular surface squamous neoplasia: systematic review and meta-analysis.
Kozma K; Dömötör ZR; Csutak A; Szabó L; Hegyi P; Erőss B; Helyes Z; Molnár Z; Dembrovszky F; Szalai E
Sci Rep; 2022 Aug; 12(1):14221. PubMed ID: 35987957
[TBL] [Abstract][Full Text] [Related]
42. Amniotic Membrane Grafting for Ocular Surface Inflammation Following Topical Interferon Alpha 2b Therapy.
Shah SG; Mishra DK; Shah GY
J Interferon Cytokine Res; 2022 Mar; 42(3):137-139. PubMed ID: 35298286
[TBL] [Abstract][Full Text] [Related]
43. Topical interferon alpha-2b for treatment of noninvasive ocular surface squamous neoplasia with 360° limbal involvement.
Zarei-Ghanavati S; Alizadeh R; Deng SX
J Ophthalmic Vis Res; 2014; 9(4):423-6. PubMed ID: 25709765
[TBL] [Abstract][Full Text] [Related]
44. Topical Chemotherapy for Treating Ocular Surface Squamous Neoplasia with a Combination of Interferon α-2b and 5-Fluorouracil.
Geng W; Wang JS; Shi BJ; Xie HT; Zhang MC
Ophthalmol Ther; 2022 Aug; 11(4):1563-1576. PubMed ID: 35704159
[TBL] [Abstract][Full Text] [Related]
45. Utility of high-resolution anterior segment optical coherence tomography in the diagnosis and management of sub-clinical ocular surface squamous neoplasia.
Tran AQ; Venkateswaran N; Galor A; Karp CL
Eye Vis (Lond); 2019; 6():27. PubMed ID: 31463333
[TBL] [Abstract][Full Text] [Related]
46. Ocular Surface Squamous Neoplasia Associated with Atopic Keratoconjunctivitis.
Shah A; Espana EM; Singh AD
Ocul Oncol Pathol; 2017 Jan; 3(1):22-27. PubMed ID: 28275599
[TBL] [Abstract][Full Text] [Related]
47. Topical interferon alpha-2b for a giant ocular surface squamous neoplasia: 7 years of follow-up after complete remission.
Galvis V; Moreno NJ; Tello A; Carreño NI
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33608345
[TBL] [Abstract][Full Text] [Related]
48. Novel ocular immunotherapy induces tumor regression in an equine model of ocular surface squamous neoplasia.
Wotman KL; Chow L; Martabano B; Pezzanite LM; Dow S
Cancer Immunol Immunother; 2023 May; 72(5):1185-1198. PubMed ID: 36367558
[TBL] [Abstract][Full Text] [Related]
49. Topical 5-Fluorouracil 1% as Primary Treatment for Ocular Surface Squamous Neoplasia.
Joag MG; Sise A; Murillo JC; Sayed-Ahmed IO; Wong JR; Mercado C; Galor A; Karp CL
Ophthalmology; 2016 Jul; 123(7):1442-8. PubMed ID: 27030104
[TBL] [Abstract][Full Text] [Related]
50. Pegylated Interferon Alpha 2a for the Treatment of Ocular Surface Squamous Neoplasia.
Park J; Han J; Chung TY; Lim DH; Choi CY
Cornea; 2022 Oct; 41(10):1271-1275. PubMed ID: 36107845
[TBL] [Abstract][Full Text] [Related]
51. Mitomycin C as an adjunct in the treatment of localised ocular surface squamous neoplasia.
Chen C; Louis D; Dodd T; Muecke J
Br J Ophthalmol; 2004 Jan; 88(1):17-8. PubMed ID: 14693762
[TBL] [Abstract][Full Text] [Related]
52. Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia.
Kusumesh R; Ambastha A; Kumar S; Sinha BP; Imam N
Cornea; 2017 Mar; 36(3):327-331. PubMed ID: 28079688
[TBL] [Abstract][Full Text] [Related]
53. The Management of Ocular Surface Squamous Neoplasia (OSSN).
Yeoh CHY; Lee JJR; Lim BXH; Sundar G; Mehta JS; Chan ASY; Lim DKA; Watson SL; Honavar SG; Manotosh R; Lim CHL
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614155
[TBL] [Abstract][Full Text] [Related]
54. Ocular surface squamous neoplasia after corneal graft.
Ramasubramanian A; Shields CL; Sinha N; Shields JA
Am J Ophthalmol; 2010 Jan; 149(1):62-5. PubMed ID: 19846060
[TBL] [Abstract][Full Text] [Related]
55. Usefulness of Topical Interferon Alpha-2b Eye Drop as an Adjunctive Therapy Following Surgical Resection in Ocular Surface Squamous Neoplasia.
Kanaya R; Kase S; Ishijima K; Ishida S
In Vivo; 2019; 33(6):2211-2215. PubMed ID: 31662558
[TBL] [Abstract][Full Text] [Related]
56. Topical Interferon Alpha-2b Induced Reactive Lymphoid Hyperplasia Masquerading as Orbital Extension of Ocular Surface Squamous Neoplasia.
Lee GA; Hess L; Glasson WJ; Whitehead K
Cornea; 2018 Jun; 37(6):796-798. PubMed ID: 29489517
[TBL] [Abstract][Full Text] [Related]
57. Ocular surface squamous neoplasia: a standard of care survey.
Stone DU; Butt AL; Chodosh J
Cornea; 2005 Apr; 24(3):297-300. PubMed ID: 15778602
[TBL] [Abstract][Full Text] [Related]
58. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
Schechter BA; Schrier A; Nagler RS; Smith EF; Velasquez GE
Cornea; 2002 Jan; 21(1):6-11. PubMed ID: 11805499
[TBL] [Abstract][Full Text] [Related]
59. Bilateral ocular surface squamous neoplasia: A study of 25 patients and review of literature.
Vempuluru VS; Pattnaik M; Ghose N; Kaliki S
Eur J Ophthalmol; 2022 Jan; 32(1):620-627. PubMed ID: 33818167
[TBL] [Abstract][Full Text] [Related]
60. Ocular surface squamous neoplasia as the initial presenting sign of human immunodeficiency virus infection in 60 Asian Indian patients.
Kaliki S; Kamal S; Fatima S
Int Ophthalmol; 2017 Oct; 37(5):1221-1228. PubMed ID: 27826936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
